Insider Selling: Liquidia Technologies, Inc. (NASDAQ:LQDA) Insider Sells 2,673 Shares of Stock

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) insider Sarah Krepp sold 2,673 shares of the business's stock in a transaction dated Monday, July 14th. The shares were sold at an average price of $14.28, for a total transaction of $38,170.44. Following the completion of the transaction, the insider owned 142,499 shares in the company, valued at approximately $2,034,885.72. This trade represents a 1.84% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Liquidia Technologies Trading Down 2.2%

Shares of LQDA traded down $0.32 on Wednesday, reaching $14.19. 1,609,495 shares of the company's stock were exchanged, compared to its average volume of 1,307,739. The company has a current ratio of 2.93, a quick ratio of 2.91 and a debt-to-equity ratio of 2.08. The stock has a market capitalization of $1.21 billion, a P/E ratio of -8.98 and a beta of -0.01. The business has a 50 day moving average price of $14.89 and a two-hundred day moving average price of $14.46. Liquidia Technologies, Inc. has a 12 month low of $8.26 and a 12 month high of $19.41.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported ($0.45) earnings per share for the quarter, missing analysts' consensus estimates of ($0.42) by ($0.03). The business had revenue of $3.12 million for the quarter, compared to the consensus estimate of $3.23 million. Liquidia Technologies had a negative return on equity of 177.91% and a negative net margin of 903.80%. Research analysts anticipate that Liquidia Technologies, Inc. will post -1.51 earnings per share for the current year.

Institutional Investors Weigh In On Liquidia Technologies

A number of institutional investors and hedge funds have recently modified their holdings of LQDA. Vanguard Group Inc. increased its stake in Liquidia Technologies by 3.4% in the fourth quarter. Vanguard Group Inc. now owns 3,557,296 shares of the company's stock valued at $41,834,000 after purchasing an additional 115,367 shares in the last quarter. LM Advisors LLC bought a new stake in Liquidia Technologies in the fourth quarter valued at approximately $25,948,000. Whitefort Capital Management LP increased its stake in Liquidia Technologies by 16.8% in the fourth quarter. Whitefort Capital Management LP now owns 1,987,245 shares of the company's stock valued at $23,370,000 after purchasing an additional 285,220 shares in the last quarter. Vestal Point Capital LP increased its stake in Liquidia Technologies by 17.3% in the fourth quarter. Vestal Point Capital LP now owns 1,760,000 shares of the company's stock valued at $20,698,000 after purchasing an additional 260,000 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in Liquidia Technologies by 8.2% in the fourth quarter. Geode Capital Management LLC now owns 1,339,254 shares of the company's stock valued at $15,753,000 after purchasing an additional 101,597 shares in the last quarter. 64.54% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have commented on LQDA shares. HC Wainwright boosted their price target on shares of Liquidia Technologies from $29.00 to $35.00 and gave the company a "buy" rating in a research report on Wednesday, May 28th. BTIG Research reaffirmed a "buy" rating on shares of Liquidia Technologies in a research note on Tuesday, May 27th. Oppenheimer set a $13.00 target price on shares of Liquidia Technologies and gave the stock an "underperform" rating in a research note on Monday, May 19th. Raymond James Financial boosted their target price on shares of Liquidia Technologies from $27.00 to $29.00 and gave the stock a "strong-buy" rating in a research note on Friday, May 9th. Finally, Wall Street Zen raised shares of Liquidia Technologies from a "sell" rating to a "hold" rating in a research note on Thursday, May 22nd. One research analyst has rated the stock with a sell rating, one has given a hold rating, six have issued a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $26.89.

About Liquidia Technologies

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).